Business Wire

Heathrow selects Smiths Detection for its next generation cabin baggage and security screening equipment

26.3.2021 10:00:00 EET | Business Wire | Press release

Share

Smiths Detection, a global leader in threat detection and security screening technologies, today announces that it has been chosen to supply integrated checkpoints throughout Heathrow Airport, featuring the HI-SCAN 6040 CTiX computed tomography X-rays, to deliver an advanced level of security and efficiency.

The ECAC EDS CB C3 approved CT systems will see Heathrow meet the highest regulatory requirements, while helping the leading airport achieve its vision for the future of the security checkpoint for passengers and colleagues. The integrated checkpoints feature iLane automatic tray return systems and Checkpoint.Evoplus, Smiths Detection’s checkpoint operation management solution. The award also includes a 10-year equipment service agreement.

“We are delighted to once again be given the opportunity to work closely with Heathrow Airport to provide leading-edge technologies that bring the best security outcomes and passenger experience,” said Smiths Detection President, Roland Carter. “Both Smiths Detection and Heathrow are focused on intelligent solutions that deliver efficiency, security and resilience; and these new lanes will allow for improvements to be easily integrated as technology develops.”

As part of its decision making, Heathrow sought a supplier that could deliver a large scale, innovative, end-to-end solution and integrate the lanes into the airports’ existing operational environment with no impact to capacity or passenger experience.

Each piece of the integrated checkpoint uses Smiths Detection’s leading-edge technology designed to help increase security, improve passenger experience, and enhance operational efficiency:

  • HI-SCAN 6040 CTiX – This CT technology cabin baggage screening system provides the highest level of detection using 3D images with low false alarm rates. It delivers advanced explosives detection and can allow for electronics and liquids to remain in bags, helping to expedite the screening process.
  • Checkpoint.Evoplus fully integrates the checkpoint by combining individual components of the lane onto a single, intelligent operational management solution. It enables centralised screening by delivering scanned images to operators based at separate locations, resulting in optimised resources management and reduced operational costs.
  • iLane - a family of automatic tray return systems that use a modular smart lane design. By delivering a steady flow of trays, iLanes help remove bottlenecks and streamline the screening process to deliver higher throughput. The family includes iLane Selfcair, iLane.evo, and iLane.pro.

This contract is part of a long-term relationship between Heathrow and Smiths Detection, which includes the supply of industry leading hold baggage CT solutions.

The first lanes will be installed in anticipation of a recovery in passenger numbers later this year.

###

About Smiths Detection

Smiths Detection is a global leader in threat detection and screening technologies for aviation, ports and borders, urban security and defence. With more than 40 years of field-tested experience, we deliver the solutions needed to protect society from the threat and illegal passage of explosives, prohibited weapons, contraband, toxic chemicals and narcotics.

Our mission is to help make the world a safer place – we do this by using technology to develop innovative solutions and services which protect life, safeguard society and uphold the free flow of trade.

For more information on Smiths Detection’s solutions and services, visit https://www.smithsdetection.com/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contacts
Tom Hufton / Georgina Reeves
FTI Consulting
sc.smithsdetection@fticonsulting.com
+44 (0)20 3727 1000

Sophie Mills
Global Communications Manager
Sophie.mills@smithsdetection.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 14:00:00 EEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 13:50:00 EEST | Press release

IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio transformation and is expected to strengthen the company’s focus on its innovation-driven businesses: Taste, Scent, and Health & Biosciences. Following the transaction, IFF will be

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 13:00:00 EEST | Press release

BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 patients, underscoring consistent effectiveness and safety in clinical practice. Additionally, BEQALZI™ (sonrotoclax), which was recently approved by the U.S. Food and Drug Administration, and its development in combination with BRUKINSA (ZS) highlight the potential for next-generation, time-limited treatment approaches in CLL. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: “CLL is a disease patients live with

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye